TickerFactsScreenerDevelopers

Semnur Pharmaceuticals, Inc. (SMNR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$426.1K2023: -$632.8K2024: -$4.89M2025: -$5.87M-$5.87M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$5.87M-20.0%
2024-$4.89M-672.9%
2023-$632.8K-48.5%
2022-$426.1K—